| TAZ: a novel transcriptional co‐activator regulated by interactions with 14‐3‐3 and PDZ domain proteins F Kanai, PA Marignani, D Sarbassova, R Yagi, RA Hall, M Donowitz, ... The EMBO journal, 2000 | 838 | 2000 |
| Multiple phosphoinositide 3-kinase-dependent steps in activation of protein kinase B MP Scheid, PA Marignani, JR Woodgett Molecular and cellular biology 22 (17), 6247-6260, 2002 | 457 | 2002 |
| Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead WH Goodson III, L Lowe, DO Carpenter, M Gilbertson, A Manaf Ali, ... Carcinogenesis 36 (Suppl_1), S254-S296, 2015 | 333 | 2015 |
| LKB1 associates with Brg1 and is necessary for Brg1-induced growth arrest PA Marignani, F Kanai, CL Carpenter Journal of Biological Chemistry 276 (35), 32415-32418, 2001 | 158 | 2001 |
| Vav2 is required for cell spreading PA Marignani, CL Carpenter The Journal of cell biology 154 (1), 177-186, 2001 | 135 | 2001 |
| Association of protein kinase Cm with type II phosphatidylinositol 4-kinase and type I phosphatidylinositol 4-phosphate 6-kinase K Nishikawa, A Toker, K Wong, PA Marignani, FJ Johannes, LC Cantley Journal of Biological Chemistry 273 (36), 23126-23133, 1998 | 113 | 1998 |
| LKB1, the multitasking tumour suppressor kinase PA Marignani Journal of clinical pathology 58 (1), 15-19, 2005 | 99 | 2005 |
| Acyl Chain Dependence of Diacylglycerol Activation of Protein Kinase C Activity in Vitro PA Marignani, RM Epand, RJ Sebaldt Biochemical and biophysical research communications 225 (2), 469-473, 1996 | 94 | 1996 |
| Activation of tumor suppressor LKB1 by honokiol abrogates cancer stem-like phenotype in breast cancer via inhibition of oncogenic Stat3 NKSDS S Sengupta, A Nagalingam, N Muniraj, MY Bonner, P Mistriotis, A ... Oncogene, doi:10.1038/onc.2017.164, 2017 | 92* | 2017 |
| Mechanisms of environmental chemicals that enable the cancer hallmark of evasion of growth suppression R Nahta, F Al-Mulla, R Al-Temaimi, A Amedei, R Andrade-Vieira, SN Bay, ... Carcinogenesis 36 (Suppl_1), S2-S18, 2015 | 72 | 2015 |
| Target gene therapy for α-fetoprotein-producing hepatocellular carcinoma by E1B55k-attenuated adenovirus M Ohashi, F Kanai, K Tateishi, H Taniguchi, PA Marignani, Y Yoshida, ... Biochemical and biophysical research communications 282 (2), 529-535, 2001 | 63 | 2001 |
| Triptolide: an inhibitor of a disintegrin and metalloproteinase 10 (ADAM10) in cancer cells R Soundararajan, R Sayat, GS Robertson, PA Marignani Cancer biology & therapy 8 (21), 2054-2062, 2009 | 57 | 2009 |
| LKB1 catalytically deficient mutants enhance cyclin D1 expression KD Scott, S Nath-Sain, MD Agnew, PA Marignani Cancer research 67 (12), 5622-5627, 2007 | 50 | 2007 |
| LKB1 catalytic activity contributes to estrogen receptor α signaling S Nath-Sain, PA Marignani Molecular biology of the cell 20 (11), 2785-2795, 2009 | 49 | 2009 |
| Loss of LKB1 expression reduces the latency of ErbB2-mediated mammary gland tumorigenesis, promoting changes in metabolic pathways R Andrade-Vieira, Z Xu, P Colp, PA Marignani PloS one 8 (2), e56567, 2013 | 46 | 2013 |
| Ranitidine modifies myeloid cell populations and inhibits breast tumor development and spread in mice A Vila-Leahey, SA Oldford, PA Marignani, J Wang, ID Haidl, JS Marshall Oncoimmunology 5 (7), e1151591, 2016 | 34 | 2016 |
| Omega-3 polyunsaturated fatty acid promotes the inhibition of glycolytic enzymes and mTOR signaling by regulating the tumor suppressor LKB1 R Andrade-Vieira, H JH, PA Marignani Cancer biology & therapy 14 (7), 2013 | 34 | 2013 |
| Pre-clinical study of drug combinations that reduce breast cancer burden due to aberrant mTOR and metabolism promoted by LKB1 loss R Andrade-Vieira, D Goguen, HA Bentley, CV Bowen, PA Marignani Oncotarget 5 (24), 12738, 2014 | 28 | 2014 |
| Novel splice isoforms of STRADα differentially affect LKB1 activity, complex assembly and subcellular localization. PA Marignani, K Scott, R Bagnulo, D Cannone, E Ferrari, A Stella, ... Cancer biology & therapy 6 (10), 1627-1631, 2007 | 25 | 2007 |
| Formation of second messenger diradylglycerol in murine peritoneal macrophages is altered after in vivo (n-3) polyunsaturated fatty acid supplementation PA Marignani, RJ Sebaldt The Journal of nutrition 125 (12), 3030-3040, 1995 | 25 | 1995 |
Lewis CantleyDana Farber Cancer Center and Harvard Medical SchoolVerified email at med.cornell.edu
